Table 1 Clinical characteristics of patients with spontaneously ruptured HCC
Index | Patients (n = 118) | % |
|---|---|---|
Age (years) | 54 ± 11 | |
Gender | ||
Male | 97 | 82.20 |
Female | 21 | 17.80 |
Cirrhosis | ||
Yes | 95 | 80.51 |
No | 23 | 19.49 |
Viral hepatitis | ||
HBV | 97 | 82.20 |
HCV | 4 | 3.39 |
None | 17 | 14.41 |
BCLC stage | ||
A | 8 | 6.78 |
B | 80 | 67.80 |
C | 30 | 25.42 |
Ruptured-lesion location | ||
Left lobe | 44 | 37.29 |
Right lobe | 74 | 62.71 |
Treatment at rupture | ||
TAE/TACE | 55 | 46.61 |
Hepatectomy | 40 | 33.90 |
Conservative | 23 | 19.49 |
Total number of tumors | ||
1 | 54 | 45.76 |
2–3 | 34 | 28.81 |
> 3 | 30 | 25.43 |
LTS (cm) | 7.70 (5.45–10.93) | |
Nodular (< 5 cm) | 30 | 25.42 |
Massive (> 5 cm) | 88 | 74.58 |
Vascular invasion | ||
No | 88 | 74.58 |
Yes | 30 | 25.42 |
Child–Pugh class | ||
A | 59 | 50.00 |
B | 43 | 36.44 |
C | 16 | 13.56 |
MELD score | 10.00 (8–13) | |
≤ 14 | 95 | 80.5 |
14–18 | 15 | 12.7 |
> 18 | 8 | 6.8 |
Treatment during follow-up | ||
No | 79 | 66.95 |
Yes | 39 | 33.05 |
AFP (ng/ml) | 427.60 (33.9–1210) | |
≤ 400 | 56 | 47.46 |
> 400 | 62 | 52.54 |
Survival time > 30 days | 94 | 79.66 |
Survival time > 1 year | 37 | 31.36 |
Median survival time (days) | 174 (45–479) | |
Median follow-up time (days) | 1292 (261–1405) | |